Article Image

IPFS News Link • Science, Medicine and Technology

Potential Arthritis Treatment Advance Blocked by FDA


Painful joint deterioration caused by osteoarthritis ranks among the most common, debilitating conditions confronting aging individuals today. It is also rapidly on the rise, in both young and old alike due to excess body weight.

An estimated 27 million Americans age 25 or older currently suffer from osteoarthritis.1 By 2030, a projected 67 million people will have doctor-diagnosed arthritis.2

A new therapy might reverse this trend. The technology is called autologous stem cell transplantation. It involves using undifferentiated cells that can develop into almost any tissue—new cartilage, tendons, ligaments, even bone—to replace damaged, arthritic joints. These cells are taken not from human embryos but from your own body!